Northwest Biotherapeutics, Inc. Stock Börse Stuttgart
Stocks
NBYB
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Börse Stuttgart
15:56:03 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 0.1310 EUR | 0.00% |
|
-18.12% | -36.41% |
| Market Cap | 255M 225M 213M 193M 362M 24.47B 366M 2.55B 984M 12.49B 957M 937M 40.21B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 351M 310M 293M 266M 498M 33.69B 503M 3.52B 1.36B 17.2B 1.32B 1.29B 55.36B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.76x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Börse StuttgartEUR
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| NWBO | Delayed | |
Börse Stuttgart
| NBYB | Delayed |
| 1 week | -18.12% | ||
| Current month | -9.03% | ||
| 1 month | -18.12% | ||
| 3 months | -21.08% | ||
| 6 months | -22.94% | ||
| Current year | -36.41% |
| 1 week | 0.12 |  | 0.18 |
| 1 month | 0.12 | | 0.19 |
| Current year | 0.1 | | 0.38 |
| 1 year | 0.1 | | 0.38 |
| 3 years | 0.1 | | 0.93 |
| 5 years | 0.1 | | 2.18 |
| 10 years | 0.1 | | 2.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 2007-05-31 |
Linda Powers
CEO | Chief Executive Officer | 71 | 2011-06-07 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 1999-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 1997-12-31 |
Linda Powers
CHM | Chairman | 71 | 2007-05-16 |
Navid Malik
BRD | Director/Board Member | 57 | 2012-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -18.12% | - | - | 260M | |
| -0.70% | -4.28% | +52.62% | +86.42% | 71.81B | |
| +0.45% | -0.82% | +38.81% | +84.19% | 60.06B | |
| +4.39% | +5.68% | +36.16% | +25.53% | 27.93B | |
| -1.73% | -4.30% | -18.37% | +357.94% | 25.7B | |
| -0.51% | -2.28% | +0.48% | -9.27% | 24.89B | |
| +0.65% | +1.67% | +26.47% | -7.62% | 20.92B | |
| +3.46% | +3.02% | +158.90% | +337.81% | 15.04B | |
| +0.48% | +0.86% | +44.56% | +168.42% | 14.46B | |
| +4.86% | +2.69% | -3.50% | +531.04% | 13.87B | |
| Average | +1.13% | -1.38% | +37.35% | +174.94% | 30.52B | |
| Weighted average by Cap. | +0.65% | -1.84% | +37.13% | +129.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.36M 32.51M 29.48M 55.27M 3.74B 55.82M 390M 150M 1.91B 146M 143M 6.14B |
| Net income | - | - |
| Net Debt | 96.08M 84.79M 80.22M 72.75M 136M 9.22B 138M 962M 371M 4.71B 361M 353M 15.15B | 125M 110M 104M 94.61M 177M 11.99B 179M 1.25B 482M 6.12B 469M 459M 19.7B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | €0.1310 | 0.00% | 250 |
| 26-09-28 | €0.1310 | -3.68% | 10,000 |
| 26-09-25 | €0.1360 | +11.48% | 26,362 |
| 26-09-24 | €0.1220 | -14.08% | 18,438 |
| 26-09-23 | €0.1420 | -11.25% | 10,500 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1495USD
Average target price
1.000USD
Spread / Average Target
+568.90%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
- NBYB Stock
Select your edition
All financial news and data tailored to specific country editions
